Unbuffered premixed ranitidine formulation
    1.
    发明授权
    Unbuffered premixed ranitidine formulation 失效
    无缓冲预混雷尼替丁配方

    公开(公告)号:US5304571A

    公开(公告)日:1994-04-19

    申请号:US910467

    申请日:1992-07-08

    摘要: A pharmaceutical composition is provided comprising an unbuffered iso-osmotic aqueous formulation containing an effective amount of ranitidine for the treatment of conditions mediated through histamine H.sub.2 receptors. The formulation has a pH of greater than or equal to 5.0 and less than 6.5 and preferably includes an osmotic adjusting agent chosen from the group consisting of dextrose and sodium chloride.

    摘要翻译: 提供了一种药物组合物,其包含含有有效量的雷尼替丁的无缓冲等渗水性制剂,用于治疗通过组胺H 2受体介导的病症。 制剂具有大于或等于5.0且小于6.5的pH,并且优选包括选自右旋糖和氯化钠的渗透调节剂。

    Unbuffered premixed ranitidine formulation
    2.
    发明授权
    Unbuffered premixed ranitidine formulation 失效
    无缓冲预混雷尼替丁配方

    公开(公告)号:US5169864A

    公开(公告)日:1992-12-08

    申请号:US793043

    申请日:1991-11-15

    摘要: A pharmaceutical composition is provided comprising an unbuffered iso-osmotic aqueous formulation containing an effective amount of ranitidine for the treatment of conditions mediated through histamine H.sub.2 receptors. The formulation has a pH of greater than or equal to 5.0 and less than 6.5 and preferably includes an osmotic adjusting agent chosen from the group consisting of dextrose and sodium chloride.

    摘要翻译: 提供了一种药物组合物,其包含含有有效量的雷尼替丁的无缓冲等渗水性制剂,用于治疗通过组胺H 2受体介导的病症。 制剂具有大于或等于5.0且小于6.5的pH,并且优选包括选自右旋糖和氯化钠的渗透调节剂。

    Premixed famotidine formulation
    3.
    发明授权
    Premixed famotidine formulation 失效
    预混法莫尼丁配方

    公开(公告)号:US5650421A

    公开(公告)日:1997-07-22

    申请号:US414433

    申请日:1995-03-31

    IPC分类号: A61K31/426 A61K31/425

    CPC分类号: A61K31/426

    摘要: A pharmaceutical composition comprising a solution having an effective amount of famotidine, the solution having a pH in the range of about 4.5 to about 8.0, and a shelf life greater than 30 days.

    摘要翻译: 一种药物组合物,其包含具有有效量的法莫替丁的溶液,所述溶液的pH在约4.5至约8.0的范围内,保质期大于30天。